Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mattson

Showing results (31-40 of 190) with videos related to

Pageof 19
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Tumour markers and oncogenes in lung cancerT P Mäkelä, K Mattson, K Alitalo
Anti-Cancer Drugs|February 1, 1995
Interferon (IFN)-alpha and IFN-gamma in combination with methotrexate: in vitro sensitivity studies in four human mesothelioma cell linesA Hand, K Pelin, K Mattson, et al.
Drugs|January 1, 1971
New drugs in tuberculosisP E Hellström, U K Repo, K Mattson
International Journal of Cancer|May 16, 1998
High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancerP Salven, T Ruotsalainen, K Mattson, et al.
American Journal of Clinical Oncology|April 1, 1990
The clinical effect of medroxyprogesterone (MPA) in elderly patients with lung cancerA Niiranen, M Kajanti, L Tammilehto, et al.
The American Review of Respiratory Disease|April 1, 1990
Changes in surfactant in bronchoalveolar lavage fluid after hemithorax irradiation in patients with mesotheliomaM Hallman, P Maasilta, L Kivisaari, et al.
Journal of Lower Genital Tract Disease|June 1, 2016
Chronic Cervicitis: Presenting Features and Response to TherapyShawn K Mattson, Julia P Polk, Paul Nyirjesy
Lancet (London, England)|February 9, 1991
Pharmacokinetics of inhaled recombinant and natural alpha interferonP Maasilta, M Halme, K Mattson, et al.
Respiratory Medicine|August 1, 1997
Phase II study of weekly gemcitabine in advanced non-small cell lung cancerM Halme, A Jekunen, K Tamminen, et al.
Lancet (London, England)|February 4, 1984
Psychometric monitoring of interferon neurotoxicityK Mattson, A Niiranen, R Laaksonen, et al.
Pageof 19

Showing results (31-40 of 190) with videos related to

Sort By:
Pageof 19
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Tumour markers and oncogenes in lung cancerT P Mäkelä, K Mattson, K Alitalo
Anti-Cancer Drugs|February 1, 1995
Interferon (IFN)-alpha and IFN-gamma in combination with methotrexate: in vitro sensitivity studies in four human mesothelioma cell linesA Hand, K Pelin, K Mattson, et al.
Drugs|January 1, 1971
New drugs in tuberculosisP E Hellström, U K Repo, K Mattson
International Journal of Cancer|May 16, 1998
High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancerP Salven, T Ruotsalainen, K Mattson, et al.
American Journal of Clinical Oncology|April 1, 1990
The clinical effect of medroxyprogesterone (MPA) in elderly patients with lung cancerA Niiranen, M Kajanti, L Tammilehto, et al.
The American Review of Respiratory Disease|April 1, 1990
Changes in surfactant in bronchoalveolar lavage fluid after hemithorax irradiation in patients with mesotheliomaM Hallman, P Maasilta, L Kivisaari, et al.
Journal of Lower Genital Tract Disease|June 1, 2016
Chronic Cervicitis: Presenting Features and Response to TherapyShawn K Mattson, Julia P Polk, Paul Nyirjesy
Lancet (London, England)|February 9, 1991
Pharmacokinetics of inhaled recombinant and natural alpha interferonP Maasilta, M Halme, K Mattson, et al.
Respiratory Medicine|August 1, 1997
Phase II study of weekly gemcitabine in advanced non-small cell lung cancerM Halme, A Jekunen, K Tamminen, et al.
Lancet (London, England)|February 4, 1984
Psychometric monitoring of interferon neurotoxicityK Mattson, A Niiranen, R Laaksonen, et al.
Pageof 19